Joseph M. Fitzgerald

Executive Vice President and President, Interventional Cardiology

Other Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Boston Scientific Corp (BSX)	Executive Vice President and Group President, Cardiovascular	$892,604	—	$4,309,282	$1,187,463	$1,458,001	$45,657	$8,042,997
2024	Boston Scientific Corp (BSX)	Executive Vice President and Group President, Cardiology	$842,360	—	$3,089,627	$899,991	$1,319,632	$34,317	$6,335,804
2023	Boston Scientific Corp (BSX)	Executive Vice President and Group President, Cardiology	$793,560	—	$2,764,794	$825,000	$1,016,657	$27,372	$5,592,519
2022	Boston Scientific Corp (BSX)	Executive Vice President and Group President, Cardiology	$740,178	—	$2,416,234	$699,996	$764,649	$23,529	$4,764,586
2021	Boston Scientific Corp (BSX)	Executive Vice President and Group President, Cardiology	$699,130	—	$2,074,084	$624,999	$843,180	$23,191	$4,309,535
2020	Boston Scientific Corp (BSX)	Executive Vice President and Group President, Cardiology	$568,679	—	$1,907,997	$1,624,991	$414,010	$22,754	$4,598,333
2019	Boston Scientific Corp (BSX)	Executive Vice President and President, Interventional Cardiology	$667,416	—	$2,103,497	$624,989	$546,760	$22,732	$4,025,457
2018	Boston Scientific Corp (BSX)	Executive Vice President and President, Interventional Cardiology	$639,958	—	$1,910,971	$624,994	$582,425	$32,636	$4,036,318
2017	Boston Scientific Corp (BSX)	Executive Vice President and President, Rhythm Management	$564,740	—	$1,435,716	$2,949,992	$595,139	$19,641	$5,838,997

No earnings-call appearances recorded yet.